Senarillos, Edelito D.
HRN: 24-02-44 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/04/2023
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
11/04/2023
11/12/2023
IV
2.25gm
TID
Sepsis
Waiting Final Action
Indication: Empirical Escalation Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes